[ad_1]
A new vaccine against HIV produced would have a global protective capacity and would be promising.
Detailed information on the vaccine that targets the immune system against various types of viruses and improves the response of the immune system to HIV in tests on 393 people was published in Lancet magazine.
Participants from the United States, Rwanda, Uganda, South Africa, and Thailand were vaccinated four times in 48 weeks, where different combinations of "mosaic" vaccines were tested on healthy subjects aged 18 to 50 years old.
It was determined that all vaccine combinations in the trials improved the immune system's response to HIV and were safe.
It has also been shown that the vaccine protects some monkeys from a virus that looks like HIV.
Scientists will study whether the immune response developed by the vaccine in the next step will prevent HIV infection in humans.
It is reported that about 37 million people in the world are HIV-carriers who cause AIDS, and 1.8 million new cases are reported each year.
It is stated that the drug Prep is effective in the prevention of HIV infection, but it must be taken at regular intervals to prevent the virus from adhering to the drug.
[ad_2]
Source link
